|1.||Kukis, D L: 1 article (09/2000)|
|2.||O'Donnell, R T: 1 article (09/2000)|
|3.||Goldstein, D S: 1 article (09/2000)|
|4.||DeNardo, G L: 1 article (09/2000)|
|5.||Kroger, L A: 1 article (09/2000)|
|6.||Shen, S: 1 article (09/2000)|
|7.||Meares, C F: 1 article (09/2000)|
|8.||DeNardo, S J: 1 article (09/2000)|
11/01/1996 - "A murine antihuman B-cell monoclonal antibody, Lym-1, has shown considerable promise for the treatment of human malignant lymphomas. "
01/01/1995 - "A murine anti-human B-cell monoclonal antibody, Lym-1, has shown considerable promise for the treatment of human malignant lymphomas and has been utilized as a new radioimmunotherapy for refractory lymphoma. "
11/01/1995 - "Lym-1-gelonin was very active in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium salt and sulforhodamine B in vitro cytotoxicity assays against the Raji lymphoma cell line and confirmed the fact that monoclonal antibody Lym-1 internalizes into human lymphoma cells. "
|2.||Burkitt Lymphoma (Burkitt's Lymphoma)
10/15/1989 - "Modulation of surface antigens of Raji Burkitt's lymphoma cells by monoclonal antibody Lym-1 was investigated by flow cytometry and radioimmunoassay (RIA). "
11/01/1995 - "Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor."
|4.||Non-Hodgkin Lymphoma (Lymphosarcoma)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||Interferon-gamma (Interferon, gamma)
|4.||Surface Antigens (Surface Antigen)
|5.||lissamine rhodamine B (sulforhodamine B)